Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Faim2 contributes to neuroprotection by erythropoietin in transient brain ischemia.

Komnig D, Gertz K, Habib P, Nolte KW, Meyer T, Brockmann MA, Endres M, Rathkolb B, Hrabě de Angelis M; German Mouse Clinic Consortium, Schulz JB, Falkenburger BH, Reich A.

J Neurochem. 2018 Jan 8. doi: 10.1111/jnc.14296. [Epub ahead of print]

PMID:
29315561
2.

ASIC1a Deficient Mice Show Unaltered Neurodegeneration in the Subacute MPTP Model of Parkinson Disease.

Komnig D, Imgrund S, Reich A, Gründer S, Falkenburger BH.

PLoS One. 2016 Nov 7;11(11):e0165235. doi: 10.1371/journal.pone.0165235. eCollection 2016.

3.

Mice lacking Faim2 show increased cell death in the MPTP mouse model of Parkinson disease.

Komnig D, Schulz JB, Reich A, Falkenburger BH.

J Neurochem. 2016 Dec;139(5):848-857. doi: 10.1111/jnc.13847. Epub 2016 Oct 11.

4.

Rab7 induces clearance of α-synuclein aggregates.

Dinter E, Saridaki T, Nippold M, Plum S, Diederichs L, Komnig D, Fensky L, May C, Marcus K, Voigt A, Schulz JB, Falkenburger BH.

J Neurochem. 2016 Sep;138(5):758-74. doi: 10.1111/jnc.13712. Epub 2016 Aug 4.

5.

Cellular models for Parkinson's disease.

Falkenburger BH, Saridaki T, Dinter E.

J Neurochem. 2016 Oct;139 Suppl 1:121-130. doi: 10.1111/jnc.13618. Epub 2016 Apr 18. Review.

6.

Quantitative properties and receptor reserve of the DAG and PKC branch of G(q)-coupled receptor signaling.

Falkenburger BH, Dickson EJ, Hille B.

J Gen Physiol. 2013 May;141(5):537-55. doi: 10.1085/jgp.201210887.

7.

Quantitative properties and receptor reserve of the IP(3) and calcium branch of G(q)-coupled receptor signaling.

Dickson EJ, Falkenburger BH, Hille B.

J Gen Physiol. 2013 May;141(5):521-35. doi: 10.1085/jgp.201210886.

8.

High Ca(2+) permeability of a peptide-gated DEG/ENaC from Hydra.

Dürrnagel S, Falkenburger BH, Gründer S.

J Gen Physiol. 2012 Oct;140(4):391-402.

9.

BASIC--a bile acid-sensitive ion channel highly expressed in bile ducts.

Wiemuth D, Sahin H, Falkenburger BH, Lefèvre CM, Wasmuth HE, Gründer S.

FASEB J. 2012 Oct;26(10):4122-30. doi: 10.1096/fj.12-207043. Epub 2012 Jun 26.

PMID:
22735174
10.

Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease.

Frank T, Klinker F, Falkenburger BH, Laage R, Lühder F, Göricke B, Schneider A, Neurath H, Desel H, Liebetanz D, Bähr M, Weishaupt JH.

Brain. 2012 Jun;135(Pt 6):1914-25. doi: 10.1093/brain/aws054. Epub 2012 Mar 16.

PMID:
22427327
11.

Membrane-localized β-subunits alter the PIP2 regulation of high-voltage activated Ca2+ channels.

Suh BC, Kim DI, Falkenburger BH, Hille B.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3161-6. doi: 10.1073/pnas.1121434109. Epub 2012 Feb 2.

12.

Triggering actin comets versus membrane ruffles: distinctive effects of phosphoinositides on actin reorganization.

Ueno T, Falkenburger BH, Pohlmeyer C, Inoue T.

Sci Signal. 2011 Dec 13;4(203):ra87. doi: 10.1126/scisignal.2002033.

13.

Phosphoinositides: lipid regulators of membrane proteins.

Falkenburger BH, Jensen JB, Dickson EJ, Suh BC, Hille B.

J Physiol. 2010 Sep 1;588(Pt 17):3179-85. doi: 10.1113/jphysiol.2010.192153. Epub 2010 Jun 2. Review.

14.

PKC links Gq-coupled receptors to DAT-mediated dopamine release.

Opazo F, Schulz JB, Falkenburger BH.

J Neurochem. 2010 Jul;114(2):587-96. doi: 10.1111/j.1471-4159.2010.06788.x. Epub 2010 Apr 29.

15.

Kinetics of PIP2 metabolism and KCNQ2/3 channel regulation studied with a voltage-sensitive phosphatase in living cells.

Falkenburger BH, Jensen JB, Hille B.

J Gen Physiol. 2010 Feb;135(2):99-114. doi: 10.1085/jgp.200910345.

16.

Kinetics of M1 muscarinic receptor and G protein signaling to phospholipase C in living cells.

Falkenburger BH, Jensen JB, Hille B.

J Gen Physiol. 2010 Feb;135(2):81-97. doi: 10.1085/jgp.200910344.

17.

Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models.

Karpinar DP, Balija MB, Kügler S, Opazo F, Rezaei-Ghaleh N, Wender N, Kim HY, Taschenberger G, Falkenburger BH, Heise H, Kumar A, Riedel D, Fichtner L, Voigt A, Braus GH, Giller K, Becker S, Herzig A, Baldus M, Jäckle H, Eimer S, Schulz JB, Griesinger C, Zweckstetter M.

EMBO J. 2009 Oct 21;28(20):3256-68. doi: 10.1038/emboj.2009.257. Epub 2009 Sep 10.

18.

Neuroligin 2 controls the maturation of GABAergic synapses and information processing in the retina.

Hoon M, Bauer G, Fritschy JM, Moser T, Falkenburger BH, Varoqueaux F.

J Neurosci. 2009 Jun 24;29(25):8039-50. doi: 10.1523/JNEUROSCI.0534-09.2009.

19.

Aggregate formation and toxicity by wild-type and R621C synphilin-1 in the nigrostriatal system of mice using adenoviral vectors.

Krenz A, Falkenburger BH, Gerhardt E, Drinkut A, Schulz JB.

J Neurochem. 2009 Jan;108(1):139-46. doi: 10.1111/j.1471-4159.2008.05755.x.

20.

Accumulation and clearance of alpha-synuclein aggregates demonstrated by time-lapse imaging.

Opazo F, Krenz A, Heermann S, Schulz JB, Falkenburger BH.

J Neurochem. 2008 Jul;106(2):529-40. doi: 10.1111/j.1471-4159.2008.05407.x. Epub 2008 Apr 10.

21.

Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease.

Nagel F, Falkenburger BH, Tönges L, Kowsky S, Pöppelmeyer C, Schulz JB, Bähr M, Dietz GP.

J Neurochem. 2008 May;105(3):853-64. doi: 10.1111/j.1471-4159.2007.05204.x. Epub 2007 Dec 24.

22.

RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals.

Kowsky S, Pöppelmeyer C, Kramer ER, Falkenburger BH, Kruse A, Klein R, Schulz JB.

Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20049-54. Epub 2007 Dec 4.

23.

Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra.

Dietz GP, Stockhausen KV, Dietz B, Falkenburger BH, Valbuena P, Opazo F, Lingor P, Meuer K, Weishaupt JH, Schulz JB, Bähr M.

J Neurochem. 2008 Feb;104(3):757-65. Epub 2007 Nov 6.

24.

Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice.

Zhou H, Falkenburger BH, Schulz JB, Tieu K, Xu Z, Xia XG.

Int J Biol Sci. 2007 Mar 5;3(4):242-50.

25.

Limitations of cellular models in Parkinson's disease research.

Falkenburger BH, Schulz JB.

J Neural Transm Suppl. 2006;(70):261-8. Review.

PMID:
17017539
26.

Neuronal pathology in Parkinson's disease.

Schulz JB, Falkenburger BH.

Cell Tissue Res. 2004 Oct;318(1):135-47. Epub 2004 Sep 8. Review. Retraction in: Schulz JB. Cell Tissue Res. 2005 Apr;320(1):211.

PMID:
15365812
27.

Dendrodendritic inhibition through reversal of dopamine transport.

Falkenburger BH, Barstow KL, Mintz IM.

Science. 2001 Sep 28;293(5539):2465-70.

Supplemental Content

Loading ...
Support Center